“Empagliflozin-Induced Acute Pancreatitis and Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus”. 2022. American Journal of Chemistry and Pharmacy 1 (2): 1-4. https://doi.org/10.54536/ajcp.v1i2.747.